Table 2.
Viral genes | Key function | Relevant findings | References |
---|---|---|---|
A41L | chemokine binding protein | Deletion of A41L enhances VV immunogenicity and vaccine efficacy | [175] |
A44L | 3beta-HSD enzyme (v3beta-HSD) | A44L promotes steroid synthesis | [41, 176] |
A46R | TLR inhibitor and putative IL-1 antagonist | A46R is an inhibitor of the TLR4 signaling pathway | [41] |
A49 | Triggers Wnt signaling | A49 targets β-TrCP and thus affects multiple cellular pathways, including the NF-κB and Wnt signaling cascades | [40] |
A52R | Putative inhibitor of TLR signaling | A52R targets Toll-like receptor signaling complexes to suppress host defense | [38] |
A53R | Soluble TNF receptor | The gene deleted virus retains high immunogenicity but replication is attenuated | [177] |
B5R | Inhibits complement | Anti-B5 (EV protein) antibody-directed cell lysis via complement is a powerful mechanism for clearance of infected cells | [148] |
B8R | IFN-γ soluble receptor | B8R is a type II IFN binding protein | [36, 178] |
B13R (SPI-2) | Inhibits IL-1β converting enzyme | B13R is a nonessential immune-modulating gene that has antiapoptotic and anti-inflammatory properties with sequence homology to serine protease inhibitors (serpins) | [179] |
B15R | IL-1β soluble receptor | Deletion led to increased dendritic cell, natural killer cell, and neutrophil migration, as well as chemokine/cytokine expression | [36, 38] |
B18R | IFN-α/β soluble receptor | B18R encodes a secreted decoy receptor with a broad antagonizing effect against type I IFNs. It is good for viral replication | [180] |
C3L (VCP) | Complement control protein (VCP) | VCP modulates adaptive immune responses during infection | [181, 182] |
C6 | Binds to STA2 and inhibits type I IFN signaling | C6 is a dual function protein that inhibits the cellular responses to type I IFNs and as an inhibitor of IRF-3 activation | [183] |
C7L | Antagonizes IRF1-induced antiviral activities | C7L inhibits antiviral activities induced by Type I interferons | [184, 185] |
C12L | Binds and inhibits IL-18 | C12L promotes virulence by reducing gamma interferon production and natural killer and T-cell activity | [41, 186] |
E3L | Binds dsRNA to block PKR activation | E3 protein prevents the antiviral action of ISG15 | [187] |
F1L | Inhibits cytochrome C | F1L promotes virulence by inhibiting inflammasome activation | [188] |
K1L | Inhibits NF-κB activation | K1L supports viral replication in human cells. Deletion of the gene led to a virus that is less pathogenic due to muted innate immune responses, yet still elicits protective immunity | [39] |
K3L | The dsRNA-activated protein kinase (PKR) is inhibited by this pseudosubstrate inhibitor | K3L prevents phosphorylation of e1F2α | [189, 190] |
K7R | Promotes histone methylation associated with heterochromatin association | K7R is a virulence gene; it inhibits the NF-κB pathway and thus the migration of neutrophil cells. It affects the acute immune response | [37, 38, 191, 192] |
M1L | Associates with apoptosome | The current model is that M1L associates with and allows the formation of the apoptosome, but prevents apoptotic functions of the apoptosome | [193] |
N1L | Inhibits NF-κB | N1L is a Bcl-2-like anti-apoptotic protein. It inhibits the NK cell response | [194] |
Due to the limitation of the number of references that can be cited for this journal, not all relevant papers can be listed